⌘K

Login Start Free

Home/Filings/4/A/0001654954-20-000335

4/A//SEC Filing

JOHNSON LORIN K 4/A

Accession 0001654954-20-000335

CIK 0001540159other

View on SEC.gov Company Profile

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 8:30 AM ET

Size

9.3 KB

Accession

0001654954-20-000335

Insider Transaction Report

Form 4/AAmended

Period: 2020-01-08

Edesa Biotech, Inc.EDSA

JOHNSON LORIN K

Director

Transactions

Award
Common Share Warrants (Right to Buy)
2020-01-08+6,393→ 6,393 total
Exercise: $4.80From: 2020-07-08Exp: 2023-07-08→ Common Shares (6,393 underlying)
Award
Common Share Warrants (Right to Buy)
2020-01-08+4,262→ 4,262 total
Exercise: $4.00From: 2020-07-08Exp: 2020-11-08→ Common Shares (4,262 underlying)
Award
Common Shares
2020-01-08$4.11/sh+8,524$35,034→ 8,524 total

Footnotes (4)

[F1]The reported securities are included within 8,524 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share.
[F2]Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023.
[F3]Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020.
[F4]Amended to reflect acquisition from the issuer.

Documents

1 file

4
section16.xml
PRIMARY DOCUMENT

Issuer

Edesa Biotech, Inc.

CIK 0001540159

Entity typeother

Related Parties

1

filerCIK 0001053878

Filing Metadata

Form type: 4/A
Filed: Jan 12, 7:00 PM ET
Accepted: Jan 13, 8:30 AM ET
Size: 9.3 KB

View on SEC.gov